Senseonics Announces Preliminary Unaudited Revenue for Fourth Quarter 2025 and Provides Business Update
SENS Stock Up as Eversense 365 Enters AID Market With twiist System [Yahoo! Finance]
Senseonics Announces First Commercial Patients Using Eversense 365 Continuous Glucose Monitor (CGM) with twiist™ Automated Insulin Delivery (AID) System [Yahoo! Finance]
Senseonics Announces First Commercial Patients Using Eversense 365 Continuous Glucose Monitor (CGM) with twiist™ Automated Insulin Delivery (AID) System
Senseonics (NYSE:SENS) had its "buy" rating reaffirmed by analysts at Cowen Inc.